Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dettagli Bibliografici
Autore principale:	Zaman, Rubaiyat
Altri autori:	Sharmin, Sabrina
Natura:	Tesi
Lingua:	English
Pubblicazione:	Brac University 2024
Soggetti:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Accesso online:	http://hdl.handle.net/10361/23157

Documenti analoghi

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
di: Mostofa, Golam
Pubblicazione: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
di: Dey, Manashi
Pubblicazione: (2024)

Role of epigenetics in the development of metabolic disorders: a review
di: Mita, Tanzia Mohsin
Pubblicazione: (2024)

Role of circular RNA in neurological disease
di: Salsabil, Labiba
Pubblicazione: (2024)

Gene editing for neurodegenerative diseases-A review
di: Sharna, Anika Islam
Pubblicazione: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
di: Alim, Abdul
Pubblicazione: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
di: Annee, Israt Jahan
Pubblicazione: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
di: Afsana, Nourin
Pubblicazione: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
di: Chowdhury, Sariya Uzrat
Pubblicazione: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
di: Ferdous, Labiba
Pubblicazione: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
di: Bakar, Osama Bin Abu
Pubblicazione: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
di: Tabassum, Nadira
Pubblicazione: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
di: Islam, Md. Irfath
Pubblicazione: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
di: Shehab, Habibul Mohsin
Pubblicazione: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
di: Afreen, Nuraia
Pubblicazione: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
di: Karmaker, Swastika
Pubblicazione: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
di: Key, Nasrin Sultana
Pubblicazione: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
di: Tamanna, Mst. Taskia
Pubblicazione: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
di: Tasneem, Sadia
Pubblicazione: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
di: Ishrat, Nowshin
Pubblicazione: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
di: Saha, Bithi Rani
Pubblicazione: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
di: Chowdhury, Amal
Pubblicazione: (2024)

A review on cardiovascular development and epigenetics
di: Srity, Nafisa Alam
Pubblicazione: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
di: Hassan, Md. Muhtaz
Pubblicazione: (2020)

Marine compounds in the treatment of Alzheimer’s disease
di: Parveen, Sanjana
Pubblicazione: (2022)

Alzheimer's disease and marriage : an intimate account /
di: Wright, Lore K.
Pubblicazione: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
di: Abedin, Khondokar Mezbahul
Pubblicazione: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
di: Tasin, Md Abtahi
Pubblicazione: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
di: Aziz, Farhin
Pubblicazione: (2019)

Infection and communicable diseases /
di: Brettle, Raymond Patrick
Pubblicazione: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
di: Afra, Sumaiya
Pubblicazione: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
di: Mahee, Sadique Abdal
Pubblicazione: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
di: Rumman, Mosarrat, et al.
Pubblicazione: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
di: Rawshan, A. E. Maisha
Pubblicazione: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
di: Nayeem, Abdullah Al
Pubblicazione: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Pubblicazione: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
di: Islam, Md. Rakibul
Pubblicazione: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
di: Halim, Rabea
Pubblicazione: (2022)